SENDERO®
Smooth delivery
SENDERO
Delivery Catheters
Advanced Catheter Technology. The SENDERO Delivery Catheters are designed for smooth delivery of interventional devices, while providing optimal trackability through tortuous peripheral vessels.
SENDERO Technology
LOBO® + SENDERO
- Optimized for use with the LOBO Occluder
Highly Trackable
- Distal flexibility enables navigation through tortuosity, while proximal support enhances pushability
Smooth Device Delivery
- Lubricious PTFE liner allows for low-friction delivery of interventional devices
Precise Device Placement
- Catheter transiti ons and braided design provide support for precise placement of interventional devices
Reliable Device Retraction
- Distal column strength enables reliable retraction of interventional devices
A New Generation of Delivery Catheters.
SENDERO
MAX
for LOBO-7
and LOBO-9
SENDERO
Microcatheter
for LOBO-3
and LOBO-5
Product Information
| Model Number | Length | Catheter OD | Inner Diameter | Max Guidewire | Tip | Max Pressure | |
|---|---|---|---|---|---|---|---|
| SENDERO Microcatheter | SENDERO-MC29-130 | 130 cm | 2.9 Fr / 0.97 mm | ≤0.028” / 0.71 mm | ≤0.021” / 0.53 mm | Straight | 750 psi |
| SENDERO MAX | SENDERO-MAX55-110MP | 110 cm | 5.5 Fr / 1.83 mm | 0.059” / 1.50 mm | ≤0.038” / 0.97 mm | Multipurpose | 1000 psi |
See Instructions for Use for a complete list of warnings, precautions, and contraindications.
Indications for Use
The Okami Medical LOBO Vascular Occlusion System is intended for use to obstruct or reduce the rate of blood flow in arteries of the peripheral vasculature. The device is not indicated for use in blood vessels where crush or bend forces are anticipated (e.g. joint areas, superficial vasculature).
The SENDERO Microcatheter is intended for the peripheral vasculature for the infusion of diagnostic and therapeutic agents. The SENDERO MAX Delivery Catheter is intended for the peripheral vasculature for the infusion of diagnostic and therapeutic agents.
Rx Only: Federal (USA) law restricts device to sale by or on the order of a physician.
MRI Safety Information
Non-clinical testing and MRI simulations were performed to evaluate the LOBO Vascular Occlusion Device. Non-clinical testing demonstrated that this product is MR Conditional. A patient with an implant can be scanned safely in an MR system under the following conditions:
Static magnetic field of 1.5-Tesla and 3-Tesla, only
Maximum spatial gradient magnetic field of 4,000-gauss/cm (40-T/m)
Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 2-W/kg in the Normal Operating Mode
Under the scan conditions defined, an implant from the LOBO Vascular Occlusion Device is expected to produce a maximum temperature rise of 2˚C after 15-minutes of continuous scanning.
In non-clinical testing, the image artifact caused by the implant from the LOBO Vascular Occlusion Device extends approximately 5-mm from this device when imaged with a gradient echo pulse sequence and a 3-Tesla MR system.
Okami Medical Intellectual Property
The product(s) listed on this website, either alone or in combination with other product(s), may be protected by one or more of the identified U.S. patents. Each product may also be protected by one or more patents issued outside of the U.S., and additional patent applications related to one or more of the listed products may be pending in the U.S. or elsewhere. The absence of a product name or patent number associated with any listed product does not constitute a waiver of Okami Medical’s intellectual property rights concerning that product or patent. This website is intended to serve as notice under 35 U.S.C. § 287(a).
LOBO – U.S. Patents 10,376,267, 10,660,648 and 11,304,701.
LOBO Manufacturing – U.S. Patents 9,994,980, 10,577,733, 11,346,027, 11,885,051 and 11,898,282.
LOBO Delivery System – U.S. Patents 10,531,877 and 11,298,137.
Okami Medical, SENDERO and LOBO are registered trademarks of Okami Medical, Inc., HDBRAID is a registered trademark of Inceptus Medical LLC.
